Marley Ghizzone

2 months ago | healio.com | Marlise R. Luskin |Marley Ghizzone |Cory Perla |Mindy Valcarcel

SAN DIEGO — Marlise R. Luskin, MD, MSCE, speaks with Healio about findings from the phase 3 randomized Alliance A041501 trial. The study was put on hold due to grade 5 events among patients who received inotuzumab (Besponsa, Pfizer) and progressed onto chemotherapy, according to the abstract.

2 months ago | healio.com | Marlise R. Luskin |Marley Ghizzone |Cory Perla |Mindy Valcarcel

SAN DIEGO — In this video, Marlise R. Luskin, MD, MSCE, discusses results from a phase 3 randomized trial that investigated the addition of blinatumomab to standard chemotherapy for pediatric B-cell acute lymphoblastic leukemia.

Dec 10, 2024 | healio.com | Namrata Singh |Marley Ghizzone |Shenaz Bagha

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WASHINGTON — In this video, Namrata Singh, MD, MSCI, discusses a presentation from ACR Convergence 2024 that examined patients with rheumatoid arthritis who develop lung cancer. “The third abstract ...

Dec 9, 2024 | healio.com | Namrata Singh |Marley Ghizzone |Shenaz Bagha

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Dec 9, 2024 | healio.com | Namrata Singh |Marley Ghizzone |Shenaz Bagha

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. WASHINGTON — In this video, Namrata Singh, MD, MSCI,spotlights three important abstracts in rheumatoid arthritis presented at ACR Convergence 2024.